CDH2 and melanoma: This increase allows the preferential binding of the melanoma cells to the dermal fibroblasts over the keratinocytes as N-cadherin can trans/cis bind to the growth factor receptor on fibroblasts and activate pathways associated with invasiveness, and thus there is further loss of control of melanocyte/melanoma growth [6].